![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Bristol-Myers Squibb, Pfizer Report Results of Phase III Aristotle Trial of Eliquis
Bristol-Myers Squibb, Pfizer Report Results of Phase III Aristotle Trial of Eliquis
September 6, 2013
Bristol-Myers Squibb and Pfizer have released an analysis of the results of a Phase III trial of their blood-thinner Eliquis. The drug was being evaluated for efficacy in prevention of stroke or systemic embolism in patients with nonvalvular atrial fibrillation or atrial flutter.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
21Oct